BAFF-Rezeptor (BCMA), ein immunregulatorischer Wirkstoff

European patent · EP1806143 · Deleted

Register entry

Publication number
EP1806143
Application number
EP07100908
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 16, 2000
Published
Jul 11, 2007
Granted
Jun 15, 2016
Deleted
Aug 15, 2020
Reason
Maximum term reached
IPC classes
A61K 38/17 (2006.01)
A61K 39/395 (2006.01)
A61P 37/00 (2006.01)
A61P 9/12 (2006.01)
A61P 13/12 (2006.01)
C07K 16/28 (2006.01)
Priority
US 149378 P 17.08.1999
US 181684 P 11.02.2000
US 183536 P 18.02.2000
Divided from
EP00957502
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 17, 2020

    Maximum term reached

    Published in Swissreg on 17.08.2020

  2. Jun 15, 2016

    Granted

    Published in Swissreg on 15.06.2016

Parties

Holder

Biogen MA Inc.

250 Binney Street, Cambridge, MA 02142, US

Topotarget Switzerland SA, en liquidation

Topotarget Switzerland SA

Avenue de Sévelin 18-20, 1004 Lausanne

In liquidation

Inventor

Mackay, Fabienne

Vaucluse, NSW 2030, AU

Browning, Jeffrey

Brookline, MA 02146, US

Ambrose, Christine

Reading, MA 01867, US

Tschopp, Jurg

1066 Epalinges

Schneider, Pascal

1066 Epalinges

Thompson, Jeffrey

Stoneham, MA 02180, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.